There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This study questions whether a lower starting dose of duloxetine (DLX) could be beneficial
for patients with depression, in terms of tolerability and safety in routine clinical
care.